TABLE 1.

Patient clinical and demographic features of patients with (HPgV⁺) and without (HPgV⁻) brain detection by HPgV

Characteristic	Value(s) for:
	HPgV− (n = 6)	HPgV+ (n = 7)
Mean age [yr (+SD)]	49.5 (±6.2)	48 (±10.9)
Gender	5 male, 1 female	5 male, 2 female
Neuropathology	No anomalies (n = 4), white matter microinfarcts (n = 2)	No anomalies (n = 4), acute neuronal necrosis (CA1) (n = 1), ALS (n = 1), atherosclerosis with infarction (n = 1)
Substance use history	None reported (n = 4), occasional marijuana use (n = 1), tobacco use (n = 1)	Tobacco use, alcohol, cocaine, methamphetamine, LSD, and crystal meth use (n = 1), alcoholism with tobacco use (n=1), none reported (n = 5)
Comorbidities	None reported (n = 5), metastatic cancer (without central nervous system involvement) (n = 1)	None reported (n = 7)